ArticleCancer medicine2017

Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.

Chun-Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.